Soleno Therapeutics, Inc. (SLNO)

Price & Market Data

Price: $52.93

Daily Change: -$0.01 / 0.02%

Daily Range: $52.92 - $52.97

Market Cap: $2,758,719,488

Daily Volume: 1,774,357

Performance Metrics

1 Week: 0.02%

1 Month: 0.55%

3 Months: 30.69%

6 Months: 10.96%

1 Year: -30.99%

YTD: 14.32%

About Soleno Therapeutics, Inc. (SLNO)

A concise financial summary for Soleno Therapeutics, Inc. (SLNO). Priced at 52.93, it shows a daily movement of -$0.01 / 0.02%. Market cap: 2,758,719,488. Performance over 1-week and 1-year are key takeaways.

Company Details

Employees: 182

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

Selected stocks

Kirby Corporation (KEX)

Traeger, Inc. (COOK)

ALX Oncology Holdings Inc. (ALXO)

Central Puerto S.A. (CEPU)

B2Gold Corp (BTG)